Singapore markets closed

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.0400-0.0800 (-3.77%)
At close: 04:00PM EDT
2.0100 -0.03 (-1.47%)
After hours: 04:51PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.11-0.12-0.48-0.53
Low estimate-0.12-0.15-0.55-0.75
High estimate-0.11-0.08-0.39-0.38
Year ago EPS-0.14-0.12-0.56-0.48
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.14-0.12-0.12-0.13
Actual EPS-0.14-0.12-0.14-0.12
Difference00-0.020.01
Surprise %0.00%0.00%-16.70%7.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.11-0.12-0.48-0.53
7 days ago-0.11-0.12-0.48-0.53
30 days ago-0.11-0.12-0.48-0.53
60 days ago-0.12-0.15-0.55-0.77
90 days ago-0.12-0.14-0.49-0.53
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCRVSIndustrySector(s)S&P 500
Current qtr.21.40%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year14.30%N/AN/AN/A
Next year-10.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A